Calidi Biotherapeutics, Inc. (CLDI)
NYSEAMERICAN: CLDI · Real-Time Price · USD
0.1835
-0.0015 (-0.81%)
At close: Jun 1, 2026, 4:00 PM EDT
0.1869
+0.0034 (1.85%)
After-hours: Jun 1, 2026, 5:45 PM EDT
Calidi Biotherapeutics Market Cap
Calidi Biotherapeutics has a market cap or net worth of $2.82 million as of June 1, 2026. Its market cap has decreased by -79.00% in one year.
Market Cap
2.82M
Enterprise Value
-1.60M
1-Year Change
-79.00%
Ranking
Category
Stock Price
$0.18
Market Cap Chart
Since November 1, 2021, Calidi Biotherapeutics's market cap has decreased from $273.84M to $2.82M, a decrease of -98.97%. That is a compound annual growth rate of -63.21%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 29, 2026 | 2.85M | -66.77% |
| Dec 31, 2025 | 8.56M | -61.46% |
| Dec 31, 2024 | 22.21M | -58.52% |
| Dec 29, 2023 | 53.55M | -46.69% |
| Dec 30, 2022 | 100.46M | -64.38% |
| Dec 30, 2021 | 282.04M | 2.99% |
| Nov 1, 2021 | 273.84M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Virax Biolabs Group | 3.77M |
| Azitra | 3.72M |
| Clearmind Medicine | 3.65M |
| Adial Pharmaceuticals | 3.41M |
| GRI Bio | 2.98M |
| Oragenics | 2.73M |
| Ensysce Biosciences | 2.61M |
| Valion Bio | 2.40M |